Insider Transactions in Q2 2025 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 01
2025
|
Emil Kuriakose Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
952
-1.75%
|
$1,904
$2.49 P/Share
|